Information  X 
Enter a valid email address

HutchisonChnMedtechLtdUSD0.10 (HCM)

Date Time Source Announcement
17 Oct 2019 7:26 am
RNS
Chi-Med Ph II gastric cancer data for Savolitinib
10 Oct 2019 10:22 am
RNS
Grant of share options under share option scheme
  9:00 am
RNS
Innovent and Chi-Med Expand Global Collaboration
04 Oct 2019 7:11 am
RNS
Chi-Med Phase I/Ib Trial of HMPL-523 in Lymphoma
03 Oct 2019 8:26 am
RNS
Holding(s) in Company
30 Sep 2019 1:49 pm
RNS
Holding(s) in Company
  12:11 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Chi-Med Surufatinib Phase III data at ESMO
  7:00 am
RNS
Total Voting Rights
25 Sep 2019 7:00 am
RNS
Chi-Med Presents SANET-ep Phase III data at ESMO
18 Sep 2019 7:00 am
RNS
Chi-Med Highlights Presentations at 2019 CSCO
03 Sep 2019 7:19 am
RNS
Chi-Med to present at MS conference
  7:00 am
RNS
Chi-Med initiates Phase I trial
30 Aug 2019 7:00 am
RNS
Total Voting Rights
23 Aug 2019 7:00 am
RNS
Start of Clinical Trial in China
20 Aug 2019 7:48 am
RNS
Holding(s) in Company
30 Jul 2019 10:48 am
RNS
TR-1: Form for notification of major holdings
  7:00 am
RNS
2019 Interim Results and Clinical Programs Update
10 Jul 2019 4:35 pm
RNS
Price Monitoring Extension
03 Jul 2019 8:02 am
RNS
TR-1: Form for notification of major holdings
  7:00 am
RNS
Chi-Med to Announce 2019 Half-Year Results
  7:00 am
RNS
TR-1: Form for notification of major holdings
28 Jun 2019 11:10 am
RNS
Blocklisting Six Monthly Return
  10:07 am
RNS
Pricing of U.S. Public Secondary Offering of ADSs
  7:00 am
RNS
Secondary Offering of American Depositary Shares
21 Jun 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
19 Jun 2019 4:35 pm
RNS
Price Monitoring Extension
14 Jun 2019 9:00 am
RNS
Surufatinib Phase III Study Meets Primary Endpoint
12 Jun 2019 9:18 am
RNS
Block Admission Applications & Total Voting Rights
10 Jun 2019 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
06 Jun 2019 7:00 am
RNS
Disclosure Update
31 May 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
29 May 2019 12:06 pm
RNS
Results of Extraordinary General Meeting
22 May 2019 11:03 am
RNS
Grant of Share Options under Share Option Scheme
03 May 2019 7:00 am
RNS
Notice of EGM & Shareholder Circular
24 Apr 2019 1:54 pm
RNS
Results of AGM
15 Apr 2019 7:30 am
RNS
Disclosure Update
  7:00 am
RNS
HK Listing Application - Proposed Global Offering
29 Mar 2019 7:00 am
RNS
Start of Phase IIb/III Surufatinib Trial in China
28 Mar 2019 7:30 am
RNS
Savolitinib Lung Cancer Presentations at AACR
25 Mar 2019 7:00 am
RNS
Vesting of awards under Long Term Incentive Plan
21 Mar 2019 7:00 am
RNS
Chi-Med 2018 Annual Report and Notice of AGM
11 Mar 2019 12:54 pm
RNS
Publication of Form 20-F
  7:00 am
RNS
2018 FY Results and Key Clinical Programs Update
12 Feb 2019 7:00 am
RNS
Savolitinib PRCC Data to be presented at ASCO GU
08 Feb 2019 7:00 am
RNS
Chi-Med to Announce 2018 Final Results
07 Jan 2019 7:00 am
RNS
Chi-Med Presents at JPM Healthcare Conference
31 Dec 2018 7:00 am
RNS
Blocklisting Six Monthly Return
  7:00 am
RNS
Total Voting Rights
24 Dec 2018 12:41 pm
RNS
Second Price Monitoring Extn
  12:36 pm
RNS
Price Monitoring Extension
20 Dec 2018 7:13 am
RNS
Chi-Med announce Savolitinib program update
  7:00 am
RNS
Amendment to Lilly Agreement on Fruquintinib
14 Dec 2018 7:21 am
RNS
TR-1: Form for notification of major holdings
30 Nov 2018 7:00 am
RNS
Total Voting Rights
29 Nov 2018 8:00 am
RNS
Chi-Med Enters into Multiple Collaborations
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t